Your browser doesn't support javascript.
Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma.
Kaye, Leanne; Vuong, Vy; Barrett, Meredith A; Boers, Elroy; Guilbert, Theresa.
  • Kaye L; ResMed Science Center, San Diego, CA, USA. leanne.kaye@resmed.com.
  • Vuong V; ResMed Science Center, San Diego, CA, USA.
  • Barrett MA; ResMed Science Center, San Diego, CA, USA.
  • Boers E; ResMed Science Center, Halifax, NS, Canada.
  • Guilbert T; Department of Pediatrics, University of Cincinnati and Pulmonary Division, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
NPJ Prim Care Respir Med ; 32(1): 31, 2022 09 02.
Article in English | MEDLINE | ID: covidwho-2016705
ABSTRACT
Significant indirect healthcare costs are related to uncontrolled asthma, including productivity loss. Days with short-acting beta-agonist (SABA) use is associated with symptom-related disruptions at work, home, and school. Digital self-management platforms may support fewer days with SABA medication use and may reduce symptom-related disruptions.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma Limits: Humans Language: English Journal: NPJ Prim Care Respir Med Year: 2022 Document Type: Article Affiliation country: S41533-022-00299-3

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma Limits: Humans Language: English Journal: NPJ Prim Care Respir Med Year: 2022 Document Type: Article Affiliation country: S41533-022-00299-3